Open AccessEpidermal growth factor receptor inhibitor in advanced basal cell carcinoma
Author(s) -
Amirabadi Amir,
Alami Amirhosein,
Ahanchian Hamid,
Ariaee Nazila,
Moazzen Nasrin
Publication year - 2021
Publication title -
clinical case reports
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.4021
Subject(s) - cetuximab , medicine , basal cell carcinoma , epidermal growth factor receptor , chemotherapy , cancer research , oncology , pathology , receptor , basal cell , cancer , colorectal cancer
Cetuximab can be used for the treatment of advanced basal cell carcinoma, especially when the patient cannot tolerate routine chemotherapy. Future studies are needed to confirm it.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom